Mechanism of EVs in neurological diseases A common feature of neurodegenerative diseases is the misfolding, aggregation, and accumulation of pathologic amyloid proteins within or outside brain cells
It is not just about making the stomach smaller. At JourneyLite, we spend a lot of time helping patients understand the difference between temporary appetite control and a more anatomy-based treatment
Previous reviews have focused on the use of L
Priority was given to recent publications and high-quality evidence, with emphasis on studies published after 2022 reflecting the evolving understanding of perioperative risks
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
Breaking this cycle requires addressing the insulin signaling pathway directly, which is exactly where GLP-1 receptor agonists like semaglutide and tirzepatide show their most dramatic effects